PETRI, FRANCESCO
PETRI, FRANCESCO
Universita' degli Studi di MILANO
Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis
2026 D. Moschese, C. Fusetti, S. Lazzarin, A. Giacomelli, V. Mazzotta, D. Cattaneo, A. D'Avolio, F. Caruso, D. Maddalena, F. Petri, A. Antinori, C. Gervasoni, A. Gori, M. Vittoria Cossu
The past that haunts: lessons from missed resistance history
2026 F. Petri, V. Iannone, C. Fusetti, S. Lazzarin, A. Giacomelli, M.V. Cossu, A. Lai, A. Gori, A. Ridolfo, C.F. Perno, C. Gervasoni
Combination of laboratory automation and next-generation sequencing for the diagnosis of osteoarticular infections: a technical note
2026 S.G. Rimoldi, F. Petri, C. Pagani, D. Brioschi, M. Passerini, M. Stracuzzi, A. Gori, A. Dolci, A. Manzotti
Proximity extension assay-based targeted proteomics for biomarker discovery in adult bacterial infections
2026 E. Sguazzini, C. Montagna, T. Nayfeh, M. Offer, M. Colaneri, F. Petri, C. Banfi, C. Bonazzetti, A. Gori, M. Passerini
Battle of the Bots: Solving Clinical Cases in Osteoarticular Infections With Large Language Models
2025 F. Borgonovo, T. Matsuo, F. Petri, S.M. Amin Alavi, L.C. Mazudie Ndjonko, A. Gori, E.F. Berbari
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025
2025 D. Moschese, R. Esvan, C. Fusetti, V. Barchi, M.V. Cossu, A. Giacinta, S. Lazzarin, G. Terracini, F. Caruso, G. Micheli, D. Maddalena, G. Del Duca, F. Petri, G. Frate, M. Matone, D. Farinacci, A. Giacomelli, P. Faccendini, D. Visigalli, S. Passacantilli, A. Riva, A. Antinori, A. Gori, V. Mazzotta
High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted Interventions
2025 C. Fusetti, E. Caruso, A. Giacomelli, D. Calzavara, M.V. Cossu, N. Frattini, F. Caruso, P. Vinti, C. Atzori, F. Petri, S. Antinori, A. Gori, M. Cernuschi, D. Moschese
Defining postoperative spinal infections: navigating the inconsistencies in diagnostic definitions
2025 S.M.A. Alavi, F. Borgonovo, F. Petri, T. Matsuo, A. Gori, J.D. Shaw, A.J. Tande, E.F. Berbari
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy
2024 A. Rizzo, D. Moschese, F. Salari, A. Giacomelli, L. Morelli, M.V. Cossu, C. Fusetti, F. Petri, G. Casalini, A. Poloni, S. Lazzarin, A. Gori, S. Antinori, M.R. Gismondo, A. Lombardi, G. Rizzardini
Phage Therapy for Cardiac Implantable Electronic Devices and Vascular Grafts: A Targeted Literature Review
2024 M. Passerini, F. Petri, G.A. Suh
Wide variability of the definitions used for native vertebral osteomyelitis: walking the path for a unified diagnostic framework with a meta-epidemiological approach
2024 F. Petri, O.K. Mahmoud, S.E. Zein, S.M.A. Alavi, M. Passerini, F.E. Diehn, J.T. Verdoorn, A.J. Tande, A. Nassr, B.A. Freedman, M.H. Murad, E.F. Berbari
Culture-Negative Native Vertebral Osteomyelitis: A Narrative Review of an Underdescribed Condition
2024 S.M.A. Alavi, F. Petri, O.K. Mahmoud, R. Igwilo-Alaneme, S. El Zein, A.N. Nassr, A. Gori, E.F. Berbari
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience
2024 D. Cattaneo, M. Fusi, M. Colaneri, C. Fusetti, C. Genovese, R. Giorgi, M. Matone, S. Merli, F. Petri, A. Gori
Neurobrucellosis Presenting with Motor Damage or Hearing Loss, and Use of Steroids are Associated with a Higher Risk of Sequelae or Relapse: A Systematic Review of Individual Participant Data
2024 C. Fusetti, F. Petri, M.H. Murad, S. Merli, R. Giorgi, G. Rizzardini, A. Gori, M. Passerini
Rifampin Based Therapy for Patients with Staphylococcus aureus Native Vertebral Osteomyelitis: A Systematic Review and Meta-Analysis
2023 S. El Zein, E.F. Berbari, M. Passerini, F. Petri, J. Maamari, M.H. Murad, P. Sendi, A.J. Tande
Comorbidity Burden and Suboptimal Immunological Responses to Coronavirus Disease 2019 Vaccination in People Living with Human Immunodeficiency Virus
2022 M.V. Cossu, D. Mileto, A. Giacomelli, L. Oreni, F. Bracchitta, M. Pellicciotta, F. Salari, F. Petri, P. Meraviglia, S. Antinori, G. Rizzardini, A.L. Ridolfo
Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study
2022 A. Giacomelli, A.L. Ridolfo, L. Pezzati, L. Oreni, G. Carrozzo, M. Beltrami, A. Poloni, B. Caloni, S. Lazzarin, M. Colombo, G. Pozza, S. Pagano, S. Caronni, C. Fusetti, M. Gerbi, F. Petri, F. Borgonovo, F. D'Aloia, C. Negri, G. Rizzardini, S. Antinori
Emerging drugs for the treatment of HIV/AIDS: a review of 2019/2020 phase II and III trials
2021 M. Piscaglia, M. Cossu, M. Passerini, F. Petri, M. Gerbi, C. Fusetti, A. Capetti, G. Rizzardini
Characteristics and clinical implications of carbapenemase-producing klebsiella pneumoniae colonization and infection, Italy
2021 M. Rossi, L. Chatenoud, F. Gona, I. Sala, G. Nattino, A. D'Antonio, D. Castelli, T. Itri, P. Morelli, S. Bigoni, C. Aldieri, R. Martegani, P.A. Grossi, C. Del Curto, S. Piconi, S.G. Rimoldi, P. Brambilla, P. Bonfanti, E. van Hauwermeiren, M. Puoti, G. Gattuso, C. Cerri, M.C. Raviglione, D.M. Cirillo, A. Bandera, A. Gori, S. Battaglia, G. Lorenzin, A. Cavallero, M. Casana, D. Pocaterra, A. Cona, A. D'Arminio Monforte, G. Brigante, A. Carducci, D. Dalla Gasperina, C. Rovelli, M. Moro, P. Scarpellini, G. Rizzardini, A. Pan, A. Zoncada, M. Franzetti, A. Pandolfo, F. Castelli, E. Pollastri, G. Travi, C.S. Vismara, S. Garilli, M. Piazza, A. Regazzetti, M. Arghittu, R.M. Colombo, P. Olivieri, F. Petri, F. Averara, F. Vailati
Remdesivir in moderate to severe COVID-19 : A matter of time?
2021 C. Bonazzetti, C. Fusetti, M. Gerbi, F. Petri, A. Poloni, S. Antinori, A. Giacomelli, L. Oreni, A.L. Ridolfo, M. Pavia